Clinical trial
The Effect of Autoreactive Autoantibodies on Peripheral and Central Disease Mechanisms in Fibromyalgia.
NCT07346950 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Autoreactive Autoantibodies on Peripheral and Central Disease Mechanisms in Fibromyalgia.
- Lead sponsor
- Uppsala University
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2022
- Completion date
- December 18, 2025
- Enrollment
- 164 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.